Aspirin Discovery May Improve Cancer Treatments
Main Category: Cancer / OncologyAlso Included In: Complementary Medicine / Alternative Medicine
Article Date: 07 Apr 2007 - 1:00 PDT
| Patient / Public: | ![]() |
4.33 (3 votes) |
| Healthcare Prof: | ![]() |
3.5 (4 votes) |
Salicylates, including aspirin, are used to treat a range of inflammatory conditions and can be used to prevent diseases such as cancer, but the way aspirin works is not yet fully understood.
In a paper published in the prestigious Journal of Biological Chemistry in April, Professor Bryan Williams, Director of the Monash Institute of Medical Research, led a collaborative study that investigated the effects of salicylates on the inhibition of protein synthesis.
"Our research showed that treating human cells with salicylates results in the phosphorylation of the translation initiation factor eIF2fN, thus inhibiting protein synthesis," Professor Williams said.
"Inhibiting or slowing down protein synthesis reduces the accumulation of incorrectly folded proteins in cells, which reduces cellular stress and allows protein synthesis to return to normal."
Under conditions of cellular stress, eIF2fN is phosphorylated by a group of proteins called stress-activated kinases. One of these is protein kinase R-like endoplasmic reticulum kinase (PERK).
The research showed that salicylates caused an early increase in the phosphorylation of eIF2fN in normal mouse cells, but not in cells deficient in PERK. Aspirin was shown to activate PERK. Moreover, although aspirin inhibited protein synthesis in normal cells, this did not occur significantly in cells deficient in PERK. Thus PERK plays an important role in the inhibition of protein synthesis by salicylates.
"Our research into the mechanisms by which salicylates inhibit protein synthesis could lead to the design of more effective aspirin-like drugs for the treatment of diseases such as cancer," Professor Williams said.
###
A copy of the paper is available at: http://www.jbc.org/cgi/reprint/282/14/10164
Contact: Julie Jacobs
Research Australia
Visit our cancer / oncology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/67187.php>
APA
http://www.medicalnewstoday.com/releases/67187.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





